Congenital pulmonary valvar stenosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3189OMIM:265500Q22.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital pulmonary valvar stenosis (also known as congenital pulmonary valve stenosis or congenital pulmonic stenosis) is a heart defect present at birth in which the pulmonary valve — the valve that controls blood flow from the right ventricle of the heart to the pulmonary artery and lungs — is abnormally narrowed. This narrowing (stenosis) obstructs blood flow from the heart to the lungs, forcing the right ventricle to work harder to pump blood through the restricted valve. The condition accounts for approximately 8–10% of all congenital heart defects. The pulmonary valve leaflets are often thickened, partially fused (commissural fusion), or dome-shaped, reducing the effective valve opening. Symptoms vary depending on the severity of the stenosis. Mild cases may be asymptomatic and detected only by the presence of a heart murmur during routine examination. Moderate to severe cases can cause exertional dyspnea (shortness of breath with activity), fatigue, chest pain, cyanosis (bluish discoloration of the skin due to reduced oxygen), and in neonates with critical stenosis, heart failure. Right ventricular hypertrophy develops as the heart compensates for the increased workload. In severe or critical cases, particularly in neonates, the condition can be life-threatening without prompt intervention. The primary treatment for moderate to severe congenital pulmonary valvar stenosis is balloon valvuloplasty (also called balloon valvotomy), a catheter-based procedure that dilates the narrowed valve. This procedure has excellent long-term outcomes and is considered the first-line intervention. Surgical valvotomy or valve replacement may be necessary in cases where the valve anatomy is not amenable to balloon dilation, such as when there is significant valve dysplasia. Mild stenosis typically requires no intervention but is monitored with periodic echocardiography. With appropriate treatment, the long-term prognosis is generally very good, though some patients may require re-intervention later in life due to residual stenosis or pulmonary regurgitation.

Also known as:

Clinical phenotype terms— hover any for plain English:

Laryngeal stenosisHP:0001602
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital pulmonary valvar stenosis.

View clinical trials →

No actively recruiting trials found for Congenital pulmonary valvar stenosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital pulmonary valvar stenosis community →

No specialists are currently listed for Congenital pulmonary valvar stenosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital pulmonary valvar stenosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital pulmonary valvar stenosisForum →

No community posts yet. Be the first to share your experience with Congenital pulmonary valvar stenosis.

Start the conversation →

Latest news about Congenital pulmonary valvar stenosis

No recent news articles for Congenital pulmonary valvar stenosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital pulmonary valvar stenosis

What is Congenital pulmonary valvar stenosis?

Congenital pulmonary valvar stenosis (also known as congenital pulmonary valve stenosis or congenital pulmonic stenosis) is a heart defect present at birth in which the pulmonary valve — the valve that controls blood flow from the right ventricle of the heart to the pulmonary artery and lungs — is abnormally narrowed. This narrowing (stenosis) obstructs blood flow from the heart to the lungs, forcing the right ventricle to work harder to pump blood through the restricted valve. The condition accounts for approximately 8–10% of all congenital heart defects. The pulmonary valve leaflets are ofte

How is Congenital pulmonary valvar stenosis inherited?

Congenital pulmonary valvar stenosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital pulmonary valvar stenosis typically begin?

Typical onset of Congenital pulmonary valvar stenosis is neonatal. Age of onset can vary across affected individuals.